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CRISPR-Cas in Escherichia coli: regulation  
by H-NS, LeuO and temperature
Abstract
CRISPR-Cas adaptive immune systems are present in many bacteria and 
archaea and provide protection against invading DNA such as phages and 
plasmids. These systems are very versatile and complex in their gene compo-
sition and genomic architecture. CRISPR-Cas systems are classified into 2 
classes, 6 types and 33 subtypes although this number is not definitive and 
the research is ongoing. All CRISPR-Cas systems have been thoroughly in-
vestigated in order to better understand the mechanism of CRISPR immu-
nity enabling its use as a tool in genome editing and other biotechnological 
applications. However, regulation of the CRISPR-Cas system is also very 
complex and still not fully understood; it must provide optimal protection 
without introducing harmful consequences to the host. In this review, we 
give an overview on the regulation of the CRISPR-Cas system Class 1 Type 
I-E in Escherichia coli with the emphasis on the role of temperature in the 
regulation of the CRISPR-Cas activity and the interplay of the key regulators 
H-NS and StpA repressors and LeuO antirepressor in regulation of cas gene 
expression and HtpG chaperone in maintaining functional levels of Cas3. 
INTRODUCTION 
Clustered Regularly Interspaced Short Palindromic Repeats (CRIS-PR) and CRISPR-associated (Cas) proteins constitute the CRISPR-
Cas immune systems, which show remarkable variability in gene com-
position, gene sequences, genomic architecture and activity (regulation). 
It is present in most archaea (~90%) and many bacteria (~40%). Accord-
ing to several criteria that take into account the signature cas genes, 
phylogeny of cas1, the organization of the genes in the CRISPR-Cas loci 
and in-depth sequence and structural analysis of the effector complexes 
(1-3), CRISPR-Cas systems are classified into two distinct classes (Class 
1 and Class 2), which differ in the organization of the effector complex 
(1, 2). Class 1 CRISPR-Cas systems include types I, III, and IV, which 
utilize a multiprotein effector complex, while Class 2 CRISPR-Cas sys-
tems include types II, V and VI, which have a much simpler organiza-
tion and utilize a single multifunctional effector protein (3). Of all iden-
tified CRISPR-Cas loci, Class 2 systems are less common than Class 1, 
possibly because they are less efficient in destroying phages, but are more 
easily transformed into numerous tools in molecular biology (4). Class 
1 systems are widespread in both archaea and bacteria, while Class 2 
occur almost exclusively in bacteria (5, 6). The Type I systems contain 
seven subtypes (I-A, I-B, I-C, I-D, I-E, I-F and I-U), which are defined 
by the presence of the multiprotein crRNA-effector complex (Cascade) 
and the Cas3 signature protein (1). Cas3 protein degrades invading 
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its recognition by the effector complex. The Type I-E in 
E. coli is composed of a single operon containing cse1 
(cas8e), cse2, cas7, cas5, cas6e, cas1 and cas2 genes, the 
separate cas3 gene, and the CRISPR 1 array (8). 
Bacteria become resistant (immune) to invading DNA 
by inserting a small DNA fragment into the CRISPR 
array that consists of repeats interspaced with variable 
“spacer” sequences. Spacers originate from the invading 
DNA where they are called “protospacers”, and the pro-
cess of acquiring new spacers is called adaptation (9, 10). 
Spacers allow bacteria to memorize and recognize the 
same invading DNA in the next infection. Through the 
process called expression and maturation, the CRISPR 
array is transcribed and processed to generate crRNAs 
(CRISPR-RNA) (11). Each crRNA is composed of a par-
tial repeat(s) and a single spacer sequence. crRNA then 
assembles with Cas effector proteins into a ribonucleopro-
tein complex Cascade (CRISPR-associated complex for 
antiviral defense) that detects the complementary se-
quence in the invading DNA. An R-loop is formed when 
crRNA base pairs with the target strand of the invading 
DNA. This induces conformational change in the Cas-
cade complex that recruits endonuclease Cas3 (12) and 
triggers degradation of target DNA in the process called 
interference (reviewed in (13)).
The activity of CRISPR-Cas systems is individual and 
depends on the bacterial species. Curiously, the expression 
of the CRISPR-Cas system in wild type E. coli is considered 
silent under laboratory growth conditions (14, 15). How-
ever, regulation of the CRISPR-Cas in E. coli is very com-
plex - mediated at transcriptional and posttranslational 
level and strongly affected by the temperature of incubation 
and the cellular metabolism. The involvement of non-Cas 
protein HtpG and temperature as regulators makes CRIS-
PR-Cas Type I-E in E. coli a unique and important model 
with which to study CRISPR-Cas regulation.
CRISPR-Cas promoters and 
transcriptional regulation
The components of the CRISPR-Cas system in E. coli 
are regulated by the three independent promoters Pcas3, 
Pcas8e and Pcrispr1. The role of the fourth, anti-Pcas, is 
currently unknown, but it is assumed to have a role in 
transcription termination or prevention of the cas3 mRNA 
translation (14). anti-Pcas and Pcas8e promoters are located 
in the intergenic region ygcL-ygcB (IGLB), or cse1/casA-
cas3, but on opposite strands. Pcas8e controls expression of 
the entire cas operon, Pcas3 controls expression of the cas3 
gene, and Pcrispr1 controls pre-crRNA transcription (14). 
Pcas3 and Pcrispr1 are partially repressed while Pcas8e is 
fully repressed by the histone-like nucleoid structuring (H-
NS) protein (14–16), an abundant nucleoid-associated 
protein (NAP). H-NS is a global regulator in many Gram-
negative bacteria where it represses many genes involved in 
stress responses or changes in environmental conditions 
such as temperature, osmolarity, changes in pH or oxygen 
(17). In most cases, H-NS forms nucleoprotein complexes 
by spreading along AT-rich DNA and sterically hinders 
RNA-polymerase open complex formation (18), but it can 
also modulate expression of certain genes post-transcrip-
tionally (17). Because H-NS binds onto AT-rich sequences 
such as those found in phages and plasmids (19), it has been 
proposed that horizontally acquired genes could titrate 
H-NS from promoters as an initial, passive step in anti-H-
NS silencing. Indeed, the H-NS paralogue Sfh (Shigella 
flexneri H-NS-like) protein encoded by plasmids R27 and 
pHCM1 of Salmonella Typhimurium has been found to 
supplement the depleted population of temporarily de-
creased H-NS and enhance the fitness of bacteria when 
acquiring conjugative plasmids (20). Sfh protein also sup-
ports acquisition of plasmids by silencing CRISPR trans-
crip tion (21).
The most important step in the activation of the CRIS-
PR-Cas immunity system in E. coli is the expression of 
Cascade proteins. This is because the Cascade complex 
mediates the maturation of the crRNA by Cas6e endonu-
clease, target recognition by crRNA and target degradation 
by recruiting Cas3 (12, 22). A highly likely candidate for 
the relief of H-NS repression after titration of H-NS is the 
H-NS antagonist LeuO (transcriptional activator for 
leuABCD operon) protein. The tetrameric DNA-binding 
protein LeuO is a transcription factor from the LysR fam-
ily (23). LeuO is a pleiotropic positive regulator of many loci 
in Gram-negative bacteria, and LeuO and H-NS overlap in 
co-regulation of many target genes (78 % in E. coli and 40 
% in Salmonella enterica) where LeuO acts as an antirepres-
sor (23, 24). LeuO positively regulates its own expression 
(25), and is also repressed by H-NS and StpA in both E. coli 
and S. enterica (26–28). StpA protein (suppressor of td phe-
notype A) is a nucleoid-associated multifunctional protein 
of similar size and amino acid identity as H-NS (29). It acts 
as a transcriptional repressor (30) and an RNA chaperone 
(31). Antagonistic regulators LeuO and H-NS have been 
recently posited to act as a genetic switch. The competition 
between H-NS and LeuO for access to the same DNA 
binding sites provides the basis of this switch (21). H-NS is 
at an advantage, since it is present at constant levels through-
out the growth cycle (21), while the amounts of the LeuO 
protein will depend on its transient expression, which in 
turn depends on many conditions. Signals known to induce 
LeuO expression moderately are guanosine tetraphosphate 
(ppGpp) or amino acid starvation and stationary growth 
phase (24, 32, 33). However, neither increased transcription 
from Pcas8e nor the formation of mature crRNA has been 
detected in cells with induced stringent response either by 
amino acid starvation or serine hydroxamate (15). Thus, it 
seems that the signals that induce LeuO or decrease H-NS 
are stochastic which makes the outcome of this competition 
different in each cell within the bacterial population (21). 
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Regulation of the Cascade complex 
levels
In addition to H-NS, transcription from the Pcas8e 
promoter is repressed by the cAMP-dependent DNA-
binding protein CRP (34) and the H-NS paralogue StpA 
(35). CRP binds to a site that overlaps with a LeuO bind-
ing site, and makes CRISPR transcription dependent on 
glucose levels (34). StpA binds to the upstream region of 
the promoter Pcas8e and binds with a higher DNA bind-
ing affinity than H-NS in vitro (14). However, the silenc-
ing of CRISPR-Cas is mediated by H-NS, not by StpA in 
vivo (14). Since StpA is also repressed by H-NS (actually 
stpA and hns genes inhibit each other; (27)), it is expressed 
only in cells lacking H-NS (36). StpA can substitute for 
H-NS in one third of H-NS repressed genes acting as a 
molecular backup (36–38). StpA is rapidly degraded in 
the absence of H-NS by the Lon protease (39).
We found recently that StpA partially represses tran-
scription of the cas operon (genes cse1 (cas8e), cse2, cas7, 
cas5, cas6e, cas1, cas2) in Δhns cells. Complete derepression 
was observed in Δhns ΔstpA cells or wt cells overexpress-
ing LeuO; derepression was about 4-5-fold higher than in 
Δhns cells and about 250-fold higher than in wt cells. 
However, reduced transcription of Cascade genes in Δhns 
cells did not prevent maximal resistance to lvir phage (at 
low incubation temperature, i.e. 30 °C). The reason could 
be that sufficient amounts of Cascade complexes are syn-
thesized even with modest transcript levels (35). Another 
reason may be that only few Cascade complexes are re-
quired to establish effective immunity thanks to the very 
fast scanning ability of DNA sequences (30 ms) and 
rapid movement between the nucleoid and the cytoplasm 
(40). In E. coli, about 20 molecules of Cascade complexes 
are estimated to provide about 50 % protection against 
the target establishment (interference levels), but the best 
chance to destroy the target DNA is before replication is 
initiated, i.e. when the target is present in a single copy. 
After that, the chance to destroy multiple copies of the 
target with the CRISPR-Cas system becomes very un-
likely. Thus, a kinetic arms race takes place between the 
Cascade complex, which must find the target, and the 
invader before it gets permanently established (40).
Another layer of complexity of the system is the fact 
that destruction of the phage DNA in E. coli is strongly 
influenced by the temperature of incubation (16, 35). The 
Cas3 protein plays a critical role in this phenomenon (16). 
Regulation of the Cas3 protein levels
In general, regulation of cas3 expression is much less 
understood than that of cas operon. The cas3 gene is par-
tially negatively regulated by H-NS, and positively co-
regulated by cAMP-dependent DNA-binding protein 
CRP and the glycine cleavage system (16, 41). Increased 
transcription of cas3 was observed in stationary Δhns cells 
(16), and in late log phase cells (OD600 ~1.0) incubated 
with glycine in minimal media or in LB with elevated 
levels of cAMP (41). Discovery of a positive role of CRP 
in regulation of cas3 expression is in contrast with its 
negative role in regulation of cas operon (34). This dis-
crepancy is explained by different cell densities/growth 
phases of analyzed bacteria (41). Despite increased tran-
scription of cas3 from the Pcas3 promoter in Δhns cells with 
introduced anti-lambda spacers, cells remained sensitive 
to lvir phage infection at 37 °C unless Cas3 was over-
expressed from the plasmid or expressed from inducible 
chromosomal promoters. In addition, previous research 
found that the high-temperature protein G (HtpG) chap-
erone increases the stability and functional levels of Cas3 
for efficient CRISPR-Cas interference (42). Taken to-
gether, these results suggested that the amounts of Cas3 
protein are limiting at 37 °C (16). 
Posttranslational regulation
HtpG belongs to the Hsp90 family of highly conserved 
ATP-dependent molecular chaperones that fold and re-
model proteins. Hsp90 also functions as a “holdase” (pre-
vents aggregation of client proteins) and is not essential in 
E. coli (43). Initial research on HtpG-Cas3 interaction 
found that the CRISPR system lost its suicidal activity 
against l prophage and its ability to provide immunity 
from lysogenization at 32 °C in ΔhtpG cells (42). Overex-
pression of HtpG or Cas3 restored CRISPR activity in 
lysogenization at 32 °C, but the interaction of HtpG-Cas3 
in resistance to lvir phage infection at 37 °C is more com-
plex. That is, overexpression of Cas3 could restore resis-
tance to lvir phage infection at 30 °C without HtpG, in 
ΔhtpG Δhns cells with anti-lambda spacers, but not at 37 
°C where overexpression of Cas3 could restore resistance 
to lvir phage infection only in htpG+ Δhns cells (16). This 
corroborates the observation that the Cas3 protein requires 
HtpG at 37 °C, but the precise role of HtpG in this process 
is currently unknown. Curiously, the requirement for 
HtpG in maintaining Cas3 protein levels has been ob-
served only in E. coli (37). In other bacteria, Hsp90 has 
been shown to be essential under specific conditions – at 
higher temperatures, for cold adaptation, swarming ability, 
biofilm formation, resistance to oxidative stress and par-
ticipation in virulence (reviewed in (43)).
Regulation by temperature, supercoiling 
and growth phase
Many of the target genes that are negatively regulated 
by H-NS are regulated by environmental factors such as 
osmolarity, temperature, anaerobic stress, oxidative stress, 
pH or growth phase. These factors can induce changes in 
DNA topology (supercoiling) that can affect gene expres-
sion in response to those inducing factors (44). Therefore, 
it was proposed that the efficiency of CRISPR-Cas im-
munity can be linked to cellular metabolism via variable 
DNA supercoiling and metabolic flux (21). Negative su-
percoiling is known to stimulate R-loop formation, target 
recognition and spacer integration, which are more typi-
cal in the exponential phase of growth (10, 22, 45). There-
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fore, bacteria in an exponential growth phase are more 
likely to resist infection by the CRISPR-Cas immune 
system than bacteria in the stationary growth phase, 
which have more relaxed DNA (21). Nevertheless, activa-
tion of cas3 by cAMP or H-NS inactivation was found in 
stationary bacteria as explained previously. This discrep-
ancy can be explained by the linking number of bacterial 
DNA, which can change due to environmental stresses 
such as temperature (46). Temperature can also induce 
changes in the expression of certain genes or replication 
of the host or invading DNA (47). Indeed, the Δhns mu-
tation was shown to strongly reduce plasmid and chro-
mosomal copy number at 30 °C (48, 49). This effect was 
suggested to indirectly help CRISPR-Cas immunity to 
destroy invading DNA before replication is initiated (48). 
In Pseudomonas aeruginosa, low temperature of incubation 
was shown to promote CRISPR-Cas immunity. Specifi-
cally, CRISPR adaptation was increased as a consequence 
of the accumulation of CRISPR-Cas complexes and 
slower growth, which gave more time for invading DNA 
to be destroyed (50). Temperature is also involved in the 
regulation of H-NS and StpA. H-NS is itself cold-shock 
regulated, being stimulated 3-fold by the cold-shock pro-
tein A (CspA) (51), while transcription of stpA from its 
native promoter is 2-fold decreased at 30 °C compared to 
37 °C (36). LeuO is not temperature-regulated in wt cells 
(28), but due to reduced expression levels of StpA at low-
er temperature and its instability (39), it can be assumed 
that LeuO will have a stronger effect on activation of the 
CRISPR-Cas immunity in Δhns cells at 30 °C (35).
Concluding remarks
Antagonistic proteins H-NS and LeuO repress and 
derepress cas genes, aided by additional regulators StpA 
and cAMP-CRP to ensure sufficient amounts of Cascade 
complexes are expressed for efficient CRISPR-Cas-medi-
ated immunity. On the other hand, regulation of Cas3 by 
H-NS and CRP does not seem to provide sufficient 
amounts of Cas3 protein to resist phage infection at 37 °C 
(16). At present, we do not know whether Cas3 protein is 
unstable or whether its activity is changed at 37 °C, but 
HtpG chaperone is required to maintain functional levels 
of Cas3 (42). Given that the incubation temperature de-
termines whether cells will be resistant or sensitive to 
phage infection, we propose that incubation temperature 
is a switch that indirectly activates (turns ON) or inacti-
vates (turns OFF) CRISPR-Cas immunity in E. coli (Fig-
ure 1). In fact, the temperature represents the Cas3 activ-
ity or inactivity; at 30 °C Cas3 is active while at 37 °C 
Cas3 is inactive (when expressed from its native promoter). 
It will be interesting to determine whether there are other, 
unknown, factor(s) involved in the regulation of the Cas3 
activity or stability and why Cas3 activity is associated 
with the growth phase and temperature in E. coli. 
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Figure 1. The regulation of the CRISPR-Cas Type I-E system in E. coli is under dual regulation. Competition between antagonistic proteins 
H-NS and LeuO for binding to the Pcas8e promoter represents a genetic switch that regulates expression of Cas components (21), while the tem-
perature of incubation represents the activation switch that determines whether CRISPR-Cas immunity will be active in protecting the bacteria 
against phage infection. The roles of additional regulators, StpA, CRP-cAMP and HtpG, in the regulation of CRISPR-Cas are depicted.
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